cephalosporin c has been researched along with ru 29246 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, NX; Neu, HC; Yu, KW | 1 |
| Andrews, J; Riess, G; Thornber, D; Wise, R | 1 |
| Adam, F; Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
| Erwin, ME; Jones, RN | 1 |
| Adam, F; Bauernfeind, A; Eberlein, E; Isert, D; Jungwirth, R; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
| Bauernfeind, A; Isert, D; Jungwirth, R; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G; Wilhelm, R; Wollmann, T | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 1 |
1 trial(s) available for cephalosporin c and ru 29246
| Article | Year |
|---|---|
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
6 other study(ies) available for cephalosporin c and ru 29246
| Article | Year |
|---|---|
Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
Topics: beta-Lactamases; Cephalosporins; Drug Stability; Gram-Negative Bacteria; Hydrolysis; Microbial Sensitivity Tests | 1992 |
In vitro activity of RU 29246, the active compound of the cephalosporin prodrug ester HR 916.
Topics: Bacteroides fragilis; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Neisseria; Prodrugs; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1992 |
RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo.
Topics: Animals; Cephalosporins; Dogs; Female; Male; Mice; Pneumonia; Prodrugs; Rats; Rats, Inbred Strains; Sepsis; Tissue Distribution | 1992 |
Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
Topics: Administration, Oral; Cephalosporins; Diffusion; Humans; Microbial Sensitivity Tests | 1992 |
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.
Topics: Anti-Bacterial Agents; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Prodrugs | 1992 |
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Binding, Competitive; Carrier Proteins; Cephalosporins; Drug Stability; Gram-Negative Bacteria; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Plasmids; Prodrugs | 1992 |